News tagged ‘Leukemia’ clear
The Leukemia & Lymphoma Society and Dana-Farber joined together to establish the Blood Cancer Research Partnership, an innovative program bringing together a network of sites for clinical trial testing of blood cancer therapies in community oncology settings across the country.
Tags: BasicResearch, Leukemia, Lymphoma
Dana-Farber investigators led a phase 1 trial in which a new oral targeted drug, idelalisib, (GS-1101), showed the potential to stave off the need for additional treatments for relapsed or treatment-resistant CLL.
Tags: BasicResearch, Leukemia
Dana-Farber and Broad Institute researchers for the first time are able to show the past, present, and future of CLL tumors.
Tags: BasicResearch, Genetics, Leukemia
Dana-Farber researchers found that an experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen of care, but that the new combination could provide an alternative that could be preferable in certain scenarios.
Tags: GraftVersusHost, StemCellTransplant, Leukemia
Pediatric patients with B-precursor acute lymphoblastic leukemia who are likely to relapse after chemotherapy treatment can reduce those odds by receiving additional courses of chemotherapy, according to research by Dana-Farber/Children's Hospital Cancer Center investigators.
Tags: chemotherapy, ChildhoodCancer, Leukemia
Dana-Farber scientists have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins to which the cancers are "addicted."
Tags: BasicResearch, BreastCancer, Leukemia
Dana-Farber researchers have developed a method for determining how ready acute myeloid leukemia cells are to die, a finding that may enable oncologists to choose more effective treatments for their patients.
Tags: BasicResearch, StemCellTransplant, Leukemia
The pre-cancerous blood disorder myelodsysplastic syndrome (MDS) affects between 35,000 and 55,000 people in the United States. Dana-Farber's David Steensma, MD, discusses MDS and its treatment.
Tags: StemCellTransplant, Leukemia
Researchers at Dana-Farber/Children's Hospital Cancer Center have created a peptide that overcomes drug resistance and reactivates programmed cell death in recurrent blood cancers.
Tags: chemotherapy, DrugResistance, Leukemia, Lymphoma
Researchers have found several new altered genes that drive chronic lymphocitic leukemia through powerful DNA sequencing, a finding that could potentially help doctors predict whether a patient’s disease will progress rapidly or remain indolent for years.
Tags: BasicResearch, Leukemia